Research graph
References from Earlier Prostatic Artery Embolization for Progressive Benign Prostatic Hyperplasia: A Biological Rationale and Hypothesis for Disease Interception. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction
10.4103/0970-1591.126900 · 2014 · External reference
Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans
10.1186/s12894-018-0329-4 · 2018 · External reference
Incidence rates and risk factors for acute urinary retention: the Health Professionals Follow-up study
10.1016/s0022-5347(05)68563-1 · 1999 · External reference
Postoperative efficacy of transurethral resection of the prostate (TURP) in treating benign prostatic hyperplasia combined with detrusor underactivity
10.1097/md.0000000000046527 · 2025 · External reference
Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
10.1136/bmj.k2338 · 2018 · External reference
Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic obstruction: 5-year outcomes of a randomised, open-label, noninferiority trial
10.1016/j.euf.2024.03.001 · 2024 · External reference
Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline Amendment 2023
10.1097/ju.0000000000003698 · 2024 · External reference
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
10.1056/nejmoa030656 · 2003 · External reference
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study
10.1016/j.eururo.2009.09.035 · 2010 · External reference
Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study
10.1016/j.eururo.2014.11.006 · 2015 · External reference
The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia
10.21037/tau.2017.03.57 · 2017 · External reference
The American Urological Association symptom index for benign prostatic hyperplasia
10.1016/j.juro.2016.10.071 · 2017 · External reference
Do functional changes occur in the bladder due to bladder outlet obstruction? - ICI-RS 2018
10.1002/nau.24076 · 2019 · External reference
Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia
10.1111/j.1464-410x.2011.10430.x · 2012 · External reference
Immediate or delayed trial without catheter in acute urinary retention in males: a systematic review
10.1002/bco2.369 · 2024 · External reference
Mortality in men admitted to hospital with acute urinary retention: database analysis
10.1136/bmj.39377.617269.55 · 2007 · External reference
Blood flow, pressure and compliance in the male human bladder
10.1016/s0022-5347(05)64843-4 · 2002 · External reference
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction
10.1097/01.ju.0000139986.08972.e3 · 2004 · External reference
De-obstruction of bladder outlet in humans reverses organ remodelling by normalizing the expression of key transcription factors
10.1186/s12894-024-01417-8 · 2024 · External reference
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial
10.1016/j.lanepe.2023.100672 · 2023 · External reference
The 'prostate embolisation as first-line therapy compared to medication in treatment naïve men with prostate enlargement, a randomised controlled trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH
10.1111/bju.16479 · 2024 · External reference
Prostatic artery embolization: mid- to long-term outcomes in 1,075 patients
10.1016/j.jvir.2024.11.002 · 2025 · External reference
Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia
10.1016/j.eururo.2019.11.010 · 2020 · External reference
Prostate artery embolisation safety and efficacy: preliminary and follow-up urodynamic studies (P-EASY PLUS)
10.1111/bju.16808 · 2025 · External reference
Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-year outcomes of a randomised, open-label, single-centre trial
10.1016/j.eururo.2021.02.008 · 2021 · External reference
Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes
10.1007/s00345-022-04225-7 · 2023 · External reference
One-year outcomes after prostate artery embolization versus laser enucleation: a network meta-analysis
10.1002/bco2.302 · 2024 · External reference
Two-year outcomes of prostatic artery embolization for symptomatic benign prostatic hyperplasia: an international, multicenter, prospective study
10.1007/s00270-024-03802-0 · 2024 · External reference
Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis
10.1186/s13643-024-02514-3 · 2024 · External reference
The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction
10.1016/s0022-5347(05)63949-3 · 2003 · External reference
The incidence of acute urinary retention secondary to BPH is increasing among California men
10.1038/pcan.2013.11 · 2013 · External reference
Acute urinary retention in men: 21-year trends in incidence, subsequent benign prostatic hyperplasia-related treatment and mortality: a Danish population-based cohort study
10.1002/pros.24440 · 2023 · External reference
One-year outcomes after prostate artery embolization versus laser enucleation: a network meta-analysis
10.1002/bco2.302 · ExternalCitation · doi-reference
Immediate or delayed trial without catheter in acute urinary retention in males: a systematic review
10.1002/bco2.369 · ExternalCitation · doi-reference
Do functional changes occur in the bladder due to bladder outlet obstruction? - ICI-RS 2018
10.1002/nau.24076 · ExternalCitation · doi-reference
Acute urinary retention in men: 21-year trends in incidence, subsequent benign prostatic hyperplasia-related treatment and mortality: a Danish population-based cohort study
10.1002/pros.24440 · ExternalCitation · doi-reference
Two-year outcomes of prostatic artery embolization for symptomatic benign prostatic hyperplasia: an international, multicenter, prospective study
10.1007/s00270-024-03802-0 · ExternalCitation · doi-reference
Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes
10.1007/s00345-022-04225-7 · ExternalCitation · doi-reference
Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic obstruction: 5-year outcomes of a randomised, open-label, noninferiority trial
10.1016/j.euf.2024.03.001 · ExternalCitation · doi-reference
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study
10.1016/j.eururo.2009.09.035 · ExternalCitation · doi-reference
Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study
10.1016/j.eururo.2014.11.006 · ExternalCitation · doi-reference
Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia
10.1016/j.eururo.2019.11.010 · ExternalCitation · doi-reference
Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-year outcomes of a randomised, open-label, single-centre trial
10.1016/j.eururo.2021.02.008 · ExternalCitation · doi-reference
The American Urological Association symptom index for benign prostatic hyperplasia
10.1016/j.juro.2016.10.071 · ExternalCitation · doi-reference
Prostatic artery embolization: mid- to long-term outcomes in 1,075 patients
10.1016/j.jvir.2024.11.002 · ExternalCitation · doi-reference
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial
10.1016/j.lanepe.2023.100672 · ExternalCitation · doi-reference
The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction
10.1016/s0022-5347(05)63949-3 · ExternalCitation · doi-reference
Blood flow, pressure and compliance in the male human bladder
10.1016/s0022-5347(05)64843-4 · ExternalCitation · doi-reference
Incidence rates and risk factors for acute urinary retention: the Health Professionals Follow-up study
10.1016/s0022-5347(05)68563-1 · ExternalCitation · doi-reference
The incidence of acute urinary retention secondary to BPH is increasing among California men
10.1038/pcan.2013.11 · ExternalCitation · doi-reference
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
10.1056/nejmoa030656 · ExternalCitation · doi-reference
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction
10.1097/01.ju.0000139986.08972.e3 · ExternalCitation · doi-reference
Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline Amendment 2023
10.1097/ju.0000000000003698 · ExternalCitation · doi-reference
Postoperative efficacy of transurethral resection of the prostate (TURP) in treating benign prostatic hyperplasia combined with detrusor underactivity
10.1097/md.0000000000046527 · ExternalCitation · doi-reference
The 'prostate embolisation as first-line therapy compared to medication in treatment naïve men with prostate enlargement, a randomised controlled trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH
10.1111/bju.16479 · ExternalCitation · doi-reference
Prostate artery embolisation safety and efficacy: preliminary and follow-up urodynamic studies (P-EASY PLUS)
10.1111/bju.16808 · ExternalCitation · doi-reference
Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia
10.1111/j.1464-410x.2011.10430.x · ExternalCitation · doi-reference
Mortality in men admitted to hospital with acute urinary retention: database analysis
10.1136/bmj.39377.617269.55 · ExternalCitation · doi-reference
Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
10.1136/bmj.k2338 · ExternalCitation · doi-reference
Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans
10.1186/s12894-018-0329-4 · ExternalCitation · doi-reference
De-obstruction of bladder outlet in humans reverses organ remodelling by normalizing the expression of key transcription factors
10.1186/s12894-024-01417-8 · ExternalCitation · doi-reference
Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis
10.1186/s13643-024-02514-3 · ExternalCitation · doi-reference
The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia
10.21037/tau.2017.03.57 · ExternalCitation · doi-reference
Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction
10.4103/0970-1591.126900 · ExternalCitation · doi-reference
